Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
-
Cancer drug repurposed in fight against Alzheimer's
Disease control CompletedThis study tested whether low daily doses of nilotinib, a drug used for leukemia, could be safe and potentially slow Alzheimer's disease progression. Thirty-seven people with mild to moderate Alzheimer's took either the drug or a placebo pill for six months. Researchers measured …
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough pancreatic cancer: experimental combo targets Cancer's repair system
Disease control CompletedThis study tested whether adding a new drug called ABT-888 to standard chemotherapy could better control metastatic pancreatic cancer. The trial enrolled 64 patients whose cancer had spread and who had specific genetic risk factors or family cancer history. ABT-888 works by block…
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New software fights superbugs in the operating room
Prevention CompletedThis study tested whether a new software system could help prevent dangerous bacteria from spreading during surgery and causing infections. The software guided hospital staff on how to improve their infection control practices in real-time. Researchers compared infection rates be…
Sponsor: Georgetown University • Aim: Prevention
Last updated Apr 02, 2026 03:42 UTC